PRODUCT & PRICE REFERENCE

Exploratory Reta stack

Reta + Tesamorelin + Ipamorelin

Tesamorelin and ipamorelin records alongside separate metabolic-receptor literature.

3 products One vial of each Research catalog

Exploratory catalog selection · combination unvalidated

Evidence & research notes

No supporting controlled human study of this exact combination was identified in our September 5, 2026 review. Safety and efficacy together are unestablished. Different upstream receptor classes do not establish complementary effects. The individual studies do not validate this triple or demonstrate additional fat reduction, lean-mass preservation or metabolic protection.

Why these materials?

Collects separate tesamorelin and ipamorelin studies alongside metabolic-receptor literature. Tesamorelin is a GHRH analogue and ipamorelin is a growth-hormone secretagogue; their pathways converge on growth-hormone signaling. Retatrutide is the only metabolic-receptor anchor in this collection. Each material remains a separate product record.

  • PDL-RT3: retatrutide, an investigational GIP, GLP-1 and glucagon receptor agonist.
  • TESA: tesamorelin literature in selected clinical populations, using defined study materials.
  • Ipamorelin: secretagogue pharmacology studied in preclinical endocrine models.
Read the source studies

Published findings concern the stated study materials and models. They do not establish the exact catalog combination.

What’s included

Individual product records, together for review.

PDL-RT3 20 mg vial

1 vial

PDL-RT3 20 mg

$120

PDL-RT3 is the catalog alias for a synthetic peptide analogue in the triple incretin-receptor research class. Its laboratory record identifies the underlying analyte separately, while the catalog material is supplied as a sealed vial of lyophilized powder for analytical research.

Lot documentation published

TESA 10 mg vial

1 vial

TESA 10 mg

$65

TESA is a synthetic 44-residue analogue of human growth hormone-releasing hormone, distinguished by an N-terminal trans-3-hexenoic acid modification. It belongs to the full-length GHRH analogue family and is supplied as a sealed vial of lyophilized powder for laboratory research.

Lot documentation published

Ipamorelin 10 mg vial

1 vial

Ipamorelin 10 mg

$50

Ipamorelin is a synthetic pentapeptide containing non-proteinogenic and D-configuration residues. It belongs to the designed peptidomimetic and growth-hormone-secretagogue research class rather than a naturally occurring sequence family, and is supplied as lyophilized powder in a sealed vial.

Lot documentation published

Stack price$200

One vial of each included product.

Individual value: $235Save $35

Ask about Reta + Tesamorelin + Ipamorelin

Explore the details with our team.

Contact us for current availability and lot documentation for the products in this selection.

Laboratory research only. Goal labels describe research themes, not promised outcomes or combined-use guidance. Each product is a separate catalog record. Not for human or veterinary use.

Contact our team

Your selection

Inquiry cart

Your inquiry cart is empty.

Explore the catalog and select the materials for your research inquiry.

Explore the catalogBuild your stack